Additionally, overexpression of MDM2 protein was observed in 38% of intrahepatic cholangiocarcinoma tumors and correlated with the presence of metastases (p < 0.01) and advanced tumor stage (p < 0.05) [45]. The gene discussed is MDM2; the disease is cholangiocarcinoma.